Notes in Ewing's sarcoma

To Subscribe, use this Key

Status	Last Update	Fields
Published	02/18/2024	Paeds \| MSK \| Ewing Sarcoma \| 1.1 \| Ewings family of tumours
Published	02/18/2024	Paeds \| MSK \| Ewing Sarcoma \| 1.2 \| Epidemiology
Published	02/18/2024	Paeds \| MSK \| Ewing Sarcoma \| 1.3 \| Aetiology
Published	02/18/2024	Paeds \| MSK \| Ewing Sarcoma \| 1.4 \| Pathology
Published	02/18/2024	Paeds \| MSK \| Ewing Sarcoma \| 1.5 \| Biologic behaviour
Published	02/18/2024	Paeds \| MSK \| Ewing Sarcoma \| 1.6 \| Clinical presentation
Published	02/18/2024	Paeds \| MSK \| Ewing Sarcoma \| 1.7 \| pPNET
Published	02/18/2024	Paeds \| MSK \| Ewing Sarcoma \| 1.8 \| DDx
Published	02/18/2024	Paeds \| MSK \| Ewing Sarcoma \| 2.1 \| Workup
Published	02/18/2024	Paeds \| MSK \| Ewing Sarcoma \| 2.2 \| Staging
Published	02/18/2024	Paeds \| MSK \| Ewing Sarcoma \| 2.3 \| Prognostic factors
Published	02/18/2024	Paeds \| MSK \| Ewing Sarcoma \| 3.1 \| Management
Published	02/18/2024	Paeds \| MSK \| Ewing Sarcoma \| 3.2 \| Localised disease \| Chemotherapy
Published	02/18/2024	Paeds \| MSK \| Ewing Sarcoma \| 3.3 \| Localised disease \| Surgery
Published	02/18/2024	Paeds \| MSK \| Ewing Sarcoma \| 3.4 \| Localised disease \| Radiotherapy
Published	02/18/2024	Paeds \| MSK \| Ewing Sarcoma \| 3.5 \| Metastatic disease
Published	02/18/2024	Paeds \| MSK \| Ewing Sarcoma \| 4 \| Prognosis
Published	02/18/2024	Paeds \| MSK \| Ewing Sarcoma \| 4.2 \| Late effects of radiotherapy
Published	02/18/2024	Paeds \| MSK \| Ewing Sarcoma \| 4.3 \| Late complications of chemotherapy
Published	02/18/2024	Paeds \| MSK \| Ewing Sarcoma \| 4.4 \| Follow up
Published	02/18/2024	Paeds \| MSK \| Ewing Sarcoma \| 2.3.1 \| Assessing response to neoadjuvant chemotherapy
Published	02/18/2024	Paeds \| MSK \| Ewing Sarcoma \| 5 \| Astro 2023 summary slides
Status	Last Update	Fields